Trial Profile
Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized, Double-Blind, Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 19 Feb 2020 Status changed from recruiting to completed.
- 23 Nov 2016 New trial record